Availability of Parenteral Isoniazid -- United States
Because parenteral isoniazid is unavailable commercially, a
limited supply of this drug will now be made available through CDC
under an investigational new drug agreement for the treatment of
patients with active tuberculosis for whom the oral formulation of
the drug cannot be prescribed. Clinicians and other health-care
providers interested in obtaining this drug for their patients
should contact CDC's Clinical Research Branch, Division of
Tuberculosis Elimination, National Center for Prevention Services,
telephone (404) 639-2530.
The Food and Drug Administration is working with
pharmaceutical manufacturers to reestablish a supply of this drug;
the drug is expected to become commercially available in the United
States early next year.
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
